跳至主要内容
临床试验/NCT01218906
NCT01218906已完成不适用

Prospective Surveillance of Febrile Illness for Dengue-Endemic Areas in Asia

Sanofi0 个研究点目标入组 1,500 人开始时间: 2010年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Sanofi
入组人数
1,500
主要终点
To provide information on the incidences of febrile episodes and confirmed and probable Dengue fever, and to determine other causes of febrile episodes in the cohort population

研究概览

简要总结

The purpose of this study is to detect acute febrile episodes and dengue infection in five Asian countries, to assess dengue seroprevalence, and to assess surveillance infrastructure at investigational sites in anticipation of a Phase 3 efficacy trial of a vaccine to prevent dengue infection.

The primary objectives are:

  • To identify acute febrile episodes among the cohort in order to detect the presence of dengue infection.
  • To develop operational infrastructure for potential Phase III dengue efficacy trial sites.
  • To describe the dengue seroprevalence among the cohort at baseline and at the end of the study.

详细描述

All participants will make two visits to a study site, an enrollment visit and a termination visit. Additional visits will be made if febrile episodes occur: an acute visit and a convalescent visit. Participants or their parents/guardians will be contacted weekly to monitor the occurrence of febrile episodes and ensure appropriate assessment and care.

No vaccine will be provided or administered in this study.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
2 Years 至 14 Years(Child)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

To provide information on the incidences of febrile episodes and confirmed and probable Dengue fever, and to determine other causes of febrile episodes in the cohort population

时间窗: Up to 12 months after enrollment

次要结局

未报告次要终点

研究者

发起方
Sanofi
申办方类型
Industry
责任方
Sponsor

相似试验